InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: None

Tuesday, 04/18/2017 5:51:33 PM

Tuesday, April 18, 2017 5:51:33 PM

Post# of 233151
Tony C is the man in charge period and Lawman should be a happy camper. I too feel much more confident about the future of my investment with Tony C running the show.

Can't believe all the negative posts about this call. Obviously many looking for a quick buck. IMHO the outlook is quite favorable. Tony is proven, capable, and direct about what it is going to take. The FDA likes Pro-140 because the data up to this point is quite disruptive. Tony has two priorities. Enroll the trials and deliver the data to the FDA... and find a partner so we can discontinue the suicide raises with Paulson. I think he believes the game is going to change when we deliver Adjunct P3 PE and safety data. He felt that could be achieved simultaneously by the end of Q2. Dr. Burger stated that BTD for Adjunct would be pretty much a done deal at that point. Missing by one quarter does not signal that we are about to capsize. If the drug appeared to be headed for the ditch I'd be out. This negativity is all about having to wait another couple months for what we expected now.

P3 Mono will enroll rapidly once they complete enrollment in the P3 Adjunct. BLA submission this year.

To call this company an OTC scam is ridiculous with the reputation of Tony C and Burger alone. These guys are not going to put their name on any type of scam. Bottom line is Tony would not have taken this on if he didn't believe he could get it to the goal line.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News